Get the newest information from the Immunization Program right in your inbox!
Sign up
Trouble logging in? Forgot password? We can help!
215-685-6784
215-238-6944
Complete the online reporting agreement form
Or fill out the
then email it to
vaxreporting@phila.gov
or fax to the contact above.
Complete in addition to the reporting agreement form to onboard more than 2 clinics.
Need help? Review the FAQ
Effective immediately, all 2025-2026 COVID-19 vaccine products are no longer approved for use. Stop administering all 2025-2026 COVID-19 vaccines. Remove all 2025-2026 COVID-19 vaccines from storage units immediately, even if they are not expired. Return any unopened vials or syringes using the Returning Vaccines Guide. Note: 2026-2027 COVID-19 vaccine products...
2026-2027 VFC & VFAAR influenza products are available to order! The following products are now available to order: Flulaval (VFC & VFAAR) Fluzone (VFC-only) Flucelvax (VFC-only) FluMist (VFC-only) To place your first order: Complete a reconciliation (if it's been more than 2 weeks since your last reconciliation.) Upload your temperature data to PhilaVax. View the available influenza...
2026-2027 VFC & VFAAR influenza products are available to order! To place your first order: Complete a reconciliation (if it’s been more than 2 weeks since your last reconciliation). Upload your temperature data to PhilaVax. View the available influenza products for 2026-2027 below: View 2026-2027 Vaccine Products ...
The CDC will release RSV immunizations through the Vaccines for Children (VFC) program in monthly allotments, so it is important that you order now to ensure distribution throughout the city. Nirsevimab-alip (Beyfortus) and clesrovimab-cfor (Enflonsia) ordering is now open for the 2026-2027 season. Beyfortus and Enflonsia...
Back-to-school and respiratory disease season are just around the corner Protect patients against vaccine-preventable diseases by ordering free, educational print materials for your office! These materials can facilitate timely conversations about immunizations before the school year and respiratory disease season begin. Click the green button below or...
2026-2027 VFC & VFAAR influenza products will be available to ordersoon. Make sure your office is ready! Complete a return in PhilaVax for any 2025-2026 influenza that you stillhave on hand. A guide with step-by-step instructions is available here. Ensure your EHR/EMR is set up to report this...
Nirsevimab-alip (Beyfortus) and clesrovimab-cfor (Enflonsia) ordering is now open for the 2026-2027 season. Beyfortus and Enflonsia are monoclonal antibody immunizations used to prevent RSV infection in infants and young children that can be administered beginning on October 1, 2026. Order a 4-6-week supply now to ensure...
All VFC & VFAAR influenza vaccine supplied by the Philadelphia Immunization Program during the 2025-2026 influenza season has expired. Please account for unused VFC & VFAAR influenza vaccine using PhilaVax: Complete a return for any remaining influenza doses using PhilaVax. A guide with step-by-step instructions is available here. Return your vaccine...
Have you enrolled in the Pennsylvania Children’s Access to Routine and Essential Shots (PA CARES) program yet? If you have, no further action is needed. If not, please read on for enrollment instructions. Note that these instructions have been modified since we sent out our previous...
Good news! We're simplifying how temperature data is reported. Beginning Monday, July 13, 2026, vaccine coordinators using PDPH-issued digital data loggers (DDLs) will now submit routine temperature data through PhilaVax only. Click the button below to view the updated temperature reporting guide. View the updated guide!...
The Philadelphia Vaccines for Children (VFC) and the Vaccines for Adults at Risk (VFAAR) annual re-enrollment period is now open! To continue participating, all clinics must submit required forms by June 1, 2026. Clinics enrolled in both programs must complete separate re-enrollments for each program. Complete re-enrollment in 3...
National Infant Immunization Week highlights the importance of protecting children two years and younger from vaccine-preventable diseases. Research consistently shows that healthcare professionals are the most trusted source of vaccine information for parents. We encourage you to use this opportunity to emphasize the importance of timely...
Based on decreased RSV test positivity and pediatric hospitalizations, the Philadelphia Department of Public Health recommends stopping RSV monoclonal antibody immunization (i.e., nirsevimab and clesrovimab) to all eligible patients on April 15, 2026. Administration may continue until April 30, 2026, based on clinical judgment. Due to...
Join us for a training on pediatric immunization techniques on Friday, May 8, 2026! The Immunization Program is hosting a free training on pediatric immunization techniques for practitioners who administer or will administer Vaccines for Children (VFC) immunizations to pediatric patients. We encourage attendance by RNs,...
Adolescent Immunization Action Week (AIAW) reminds us to keep adolescents up-to-date on immunizations that protect against potentially life-threatening diseases like meningitis, tetanus, diphtheria, pertussis, HPV-related cancers, COVID-19, and influenza. Unity® Consortium offers digital and print resources that you can access online, share, or print. See below: Webinar:...
Re-Enrollment Opens May 1, 2026 The Philadelphia Vaccines for Children (VFC) and the Vaccines for Adults at Risk (VFAAR) annual re-enrollment period will take place May 1 - 31, 2026 using PhilaVax. Complete the steps below to prepare for re-enrollment. Prepare for Re-Enrollment Make sure all required staff have...
PhilaVax will be temporarily closed to new orders from Monday, March 30, 2026 through Wednesday, April 1, 2026 while immunization prices are updated for 2026. Any orders entered into PhilaVax IIS during this time will be deleted from the system and not processed. If you need to...
Increased disease activity indicates season extension The Philadelphia Department of Public Health recommends offering RSV monoclonal antibody immunization (i.e., nirsevimab and clesrovimab) to all eligible patients until April 15, 2026 due to continued RSV hospitalizations. Federally purchased RSV immunization will no longer be available to order after...